By Dr Anthony Luke Byrne

Book Chapters

Rachow A; Walker NF; Allwood B; Van Der Zalm MM; Byrne A; Meghji J, 2023, 'The challenge of post-tuberculosis lung disease', in , pp. 191 - 209, http://dx.doi.org/10.1183/2312508X.10025122

Alffenaar JWC; Kim HY; Byrne A; Piubello A; Migliori GB, 2021, 'Monitoring Treatment: Clinical and Programmatic Approach for Drug-Susceptible and Drug-Resistant Tuberculosis', in Essential Tuberculosis, pp. 163 - 170, http://dx.doi.org/10.1007/978-3-030-66703-0_18

Journal articles

Byrne A; Al-Hindawi Y; Plit M; Yeung L; Rigava S; King M; Ng K; Mungovan SF, 2025, 'The prevalence and pattern of post tuberculosis lung disease including pulmonary hypertension from an Australian TB service; a single-centre, retrospective cohort study', BMC Pulmonary Medicine, 25, http://dx.doi.org/10.1186/s12890-025-03549-5

Byrne AL; Pace NL; Thomas PS; Symons RL; Chatterji R; Bennett M, 2025, 'Peripheral venous blood gas analysis for the diagnosis of respiratory failure, hypercarbia and metabolic disturbance in adults', Cochrane Database of Systematic Reviews, 2025, http://dx.doi.org/10.1002/14651858.CD010841.pub2

Roberts DM; Liu X; Parker SL; Burke A; Peek J; Carland JE; Murnion B; Seah V; Wallis SC; Sumi CD; Pandey S; Buscher H; Byrne A; Sandaradura I; Bowen D; Holz S; Stewart AG; Hajkowicz KM; Roberts JA, 2025, 'Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19', Clinical Pharmacokinetics, 64, pp. 743 - 756, http://dx.doi.org/10.1007/s40262-025-01496-2

Noble CCA; McDonald E; Nicholson S; Biering-Sørensen S; Pittet LF; Byrne AL; Croda J; Dalcolmo M; Lacerda MVG; Lucas M; Lynn DJ; Prat Aymerich C; Richmond PC; Warris A; Curtis N; Messina NL, 2025, 'Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response', Journal of Infection, 90, http://dx.doi.org/10.1016/j.jinf.2025.106436

Messina NL; Germano S; Chung AW; van de Sandt CE; Stevens NE; Allen LF; Bonnici R; Croda J; Counoupas C; Grubor-Bauk B; Haycroft ER; Kedzierska K; McDonald E; McElroy R; Netea MG; Novakovic B; Perrett KP; Pittet LF; Purcell RA; Subbarao K; Triccas JA; Lynn DJ; Curtis N; Davidson A; Gardiner K; Gwee A; Jamieson T; Morawakage T; Perlen S; Perrett K; Sastry A; Teo JW; Orsini F; Lee K; Moore C; Vidmar S; Ali R; Dunn R; Edler P; Gell G; Goodall C; Hall R; Krastev A; La N; McPhate N; Nguyen T; Ren J; Stevens L; Alamrousi A; Dang T; Hua J; Razmovska M; Reddiex S; Wang X; Anderson J; Azzopardi K; Bennett-Wood V; Czajko A; Mazarakis N; McCafferty C; Oppedisano F; Ortika B; Pell C; Spry L; Toh R; Velagapudi S; Vlahos A; Wee-Hee A; Ramos P; De La Cruz K; Gamage D; Karunanayake A; Mezzetti I; Ong B; Singh R; Sooriyarachchi E; Nicholson S; Cain N; Brizuela R; Huang H; Abruzzo V; Bealing M; Bimboese P; Bowes K; Burrell E; Chan J; Cushnahan J; Elborough H; Elkington O; Fahey K; Fernandez M; Flynn C; Fowler S; Andrit MG, 2025, 'Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination', Clinical and Translational Immunology, 14, http://dx.doi.org/10.1002/cti2.70023

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-47720-8

Messina NL; Pittet LF; McDonald E; Moore C; Barry S; Bonten M; Byrne A; Campbell J; Croda J; Croda MG; Dalcolmo M; de Almeida e Val FF; de Oliveira RD; dos Santos G; Douglas MW; Gardiner K; Gwee A; Jardim BA; Kollmann T; Lacerda MV; Lucas M; Lynn DJ; Manning L; Marshall H; O'Connell A; Perrett KP; Post JJ; Prat-Aymerich C; Rocha JL; Rodriguez-Baño J; Wadia U; Warris A; Davidson A; Curtis N, 2024, 'BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial', Journal of Infection, 89, http://dx.doi.org/10.1016/j.jinf.2024.106245

Almeida CPB; Durand RA; LaHood AN; Byrne AL; Mendoza-Ticona A; Ygnacio E; Durand FE; Lecca L; Vásquez Pita RACL; Guerra D; Wong M; Tintaya K; Mitnick CD, 2024, '“I have to breathe”: A Mixed-Methods Pilot Study to Assess the Feasibility, Acceptability, Cost, and Effectiveness of an Intervention for Post-Tuberculosis Lung Disease', Global Journal of Health Science, 16, pp. 48 - 48, http://dx.doi.org/10.5539/gjhs.v16n8p48

Dupnik K; Rivera VR; Dorvil N; Duffus Y; Akbarnejad H; Gao Y; Liu J; Apollon A; Dumont E; Riviere C; Severe P; Lavoile K; Mendicuti MAD; Pierre S; Rouzier V; Walsh KF; Byrne AL; Joseph P; Cremieux PY; Pape JW; Koenig SP, 2024, 'Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification Among Patients With Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-income Countries', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae356

Pittet LF; Messina NL; McDonald E; Orsini F; Barry S; Bonten M; Campbell J; Croda J; Croda MG; Dalcolmo M; Gardiner K; Gwee A; Jardim B; Lacerda MVG; Lucas M; Lynn DJ; Manning L; Perrett KP; Post JJ; Prat-Aymerich C; Richmond PC; Rocha JL; Rodriguez-Baño J; Warris A; Wood NJ; Davidson A; Curtis N; Jamieson T; Morawakage T; Perlen S; Sastry A; Teo JW; Lee K; Moore C; Vidmar S; Ali R; Dunn R; Edler P; Gell G; Goodall C; Hall R; Krastev A; La N; McPhate N; Nguyen T; Ren J; Stevens L; Alamrousi A; Bonnici R; Dang T; Germano S; Hua J; McElroy R; Razmovska M; Reddiex S; Wang X; Anderson J; Azzopardi K; Bennett-Wood V; Czajko A; Mazarakis N; McCafferty C; Oppedisano F; Ortika B; Pell C; Spry L; Toh R; Velagapudi S; Vlahos A; Wee-Hee A; Ramos P; De La Cruz K; Gamage D; Karunanayake A; Mezzetti I; Ong B; Singh R; Sooriyarachchi E; Nicholson S; Cain N; Brizuela R; Huang H; Abruzzo V; Bealing M; Bimboese P; Bowes K; Burrell E; Chan J; Cushnahan J; Elborough H; Elkington O; Fahey K; Fernandez M; Flynn C; Fowler S; Andrit MG; Gladanac B; Hammond C; Ma N, 2024, 'Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial', Eclinicalmedicine, 72, http://dx.doi.org/10.1016/j.eclinm.2024.102616

Allwood B; Nightingale R; Agbota G; Auld S; Bisson GP; Byrne A; Dunn R; Evans D; Hoddinott G; Günther G; Islam Z; Johnston JC; Kalyatanda G; Khosa C; Marais S; Makanda G; Mashedi OM; Meghji J; Mitnick C; Mulder C; Nkereuwem E; Nkereuwem O; Ozoh OB; Rachow A; Romanowski K; Seddon JA; Schoeman I; Thienemann F; Walker NF; Wademan DT; Wallis R; van der Zalm MM, 2024, 'Perspectives from the 2nd International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomes', Ijtld Open, 1, pp. 111 - 123, http://dx.doi.org/10.5588/ijtldopen.23.0619

Chaganti J; Poudel G; Cysique LA; Dore GJ; Kelleher A; Matthews G; Darley D; Byrne A; Jakabek D; Zhang X; Lewis M; Jha N; Brew BJ, 2024, 'Blood brain barrier disruption and glutamatergic excitotoxicity in post-acute sequelae of SARS COV-2 infection cognitive impairment: potential biomarkers and a window into pathogenesis', Frontiers in Neurology, 15, http://dx.doi.org/10.3389/fneur.2024.1350848

Ashuro Z; Debela BG; Daba C; Hareru HE; Abaya SW; Byrne AL, 2024, 'The effect of occupational exposure to organic dust on lung function parameters among African industrial workers: a systematic review and meta-analysis', Frontiers in Public Health, 12, http://dx.doi.org/10.3389/fpubh.2024.1424315

Lewthwaite H; Byrne A; Brew B; Gibson PG, 2023, 'Treatable traits for long COVID', Respirology, 28, pp. 1005 - 1022, http://dx.doi.org/10.1111/resp.14596

Cysique LA; Jakabek D; Bracken SG; Allen-Davidian Y; Heng B; Chow S; Dehhaghi M; Staats Pires A; Darley DR; Byrne A; Phetsouphanh C; Kelleher A; Dore GJ; Matthews GV; Guillemin GJ; Brew BJ, 2023, 'The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC', Annals of Clinical and Translational Neurology, 10, pp. 1338 - 1352, http://dx.doi.org/10.1002/acn3.51825

Pham JP; Boot M; Stefani M; Chapman S; Byrne A; Abdel-Shaheed C; Girgis L, 2023, 'Disseminated Mycobacterium chelonae infection complicating rheumatoid arthritis: A case report and review of the literature', International Journal of Rheumatic Diseases, 26, pp. 1167 - 1171, http://dx.doi.org/10.1111/1756-185X.14605

Dorvil N; Rivera VR; Riviere C; Berman R; Severe P; Bang H; Lavoile K; Devieux JG; Faustin M; Saintyl G; Mendicuti MD; Pierre S; Apollon A; Dumond E; Forestal GPL; Rouzier V; Marcelin A; McNairy ML; Walsh KF; Dupnik K; Reif LK; Byrne AL; Bousleiman S; Orvis E; Joseph P; Cremieux PY; Pape JW; Koenig SP, 2023, 'Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti', Plos Medicine, 20, http://dx.doi.org/10.1371/journal.pmed.1004246

Nightingale R; Carlin F; Meghji J; McMullen K; Evans D; van der Zalm MM; Anthony MG; Bittencourt M; Byrne A; du Preez K; Coetzee M; Feris C; Goussard P; Hirasen K; Bouwer J; Hoddinott G; Huaman MA; Inglis-Jassiem G; Ivanova O; Karmadwala F; Schaaf HS; Schoeman I; Seddon JA; Sineke T; Solomons R; Thiart M; van Toorn R; Fujiwara PI; Romanowski K; Marais S; Hesseling AC; Johnston J; Allwood B; Muhwa JC; Mortimer K, 2023, 'Post-TB health and wellbeing', International Journal of Tuberculosis and Lung Disease, 27, pp. 248 - 283, http://dx.doi.org/10.5588/ijtld.22.0514

Byrne A; Allwood B; Schoeman I; Johnston J; Kalyatanda G; Makanda G; Mortimer K; Mitnick C; Nightingale R; Ozoh O; Rachow A; Van Der Zalm M, 2023, '“Post tuberculosis”: the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials', European Respiratory Journal, 62, http://dx.doi.org/10.1183/13993003.00950-2023

Messina NL; Germano S; McElroy R; Rudraraju R; Bonnici R; Pittet LF; Neeland MR; Nicholson S; Subbarao K; Curtis N; Baena AS; Teo JW; de Lima GT; Abreu C; Abruzzo V; Addlem L; Agius S; Barbosa AAR; Alamrousi A; da Silva dos Santos AA; Al-Hindawi Y; Silveira SAD; da Cruz LA; Anderson J; Nelly A; Anthony C; dos Reis Pereira AASDA; de las Revillas Almajano FA; Arnold A; Arrowsmith B; Azzopardi K; Marti CB; Bahaduri T; Bannister S; Barney S; Barrera L; Barriocanal A; Barros D; Barry S; Bartlett A; Batista L; Muranaka S; Baulman T; Bealing M; Beardsley J; Gutierrez ABM; Bell J; Benson S; Rym B; Bennett-Wood V; Bergant N; Barbosa FB; Bijllaardt W; Bimboese P; de Andrade CB; Blake S; Blauwendraat K; Boersma W; Garcia PB; Bonten M; Boon A; Bourke A; Bowes K; Brasil L; Brophy C; Botten R; Buchanan S; Bucholc J; Burns A; Burrell E; Bustos N; Byrne B; Byrne A; Calbo E; Montes JC; Camesella B; Campbell J; Cangas A; Carlin J; Roque MC; Diogo RCP; Carvalho E; Casas I; Castro E; Castro R; Catterick H; Escobar RCD; Chan J; Cheah J; Chern TY; Chengodu T; Ciaverella M; Clark S; Espindola MAC; Cobbledick A; Colaco C; Collopy S; Comella P; Corbett M; Castro GCE; Palasanthiran P; McMullan B; Perez Chacon G, 2022, 'Off-target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19', Clinical and Translational Immunology, 11, pp. e1387, http://dx.doi.org/10.1002/cti2.1387

Menzies NA; Quaife M; Allwood BW; Byrne AL; Coussens AK; Harries AD; Marx FM; Meghji J; Pedrazzoli D; Salomon JA; Sweeney S; van Kampen SC; Wallis RS; Houben RMGJ; Cohen T, 2021, 'Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae', Lancet Global Health, 9, pp. e1679 - e1687, http://dx.doi.org/10.1016/S2214-109X(21)00367-3

Alene KA; Wangdi K; Colquhoun S; Chani K; Islam T; Rahevar K; Morishita F; Byrne A; Clark J; Viney K, 2021, 'Tuberculosis related disability: a systematic review and meta-analysis', BMC Medicine, 19, http://dx.doi.org/10.1186/s12916-021-02063-9

Pittet LF; Messina NL; Gardiner K; Orsini F; Abruzzo V; Bannister S; Bonten M; Campbell JL; Croda J; Dalcolmo M; Elia S; Germano S; Goodall C; Gwee A; Jamieson T; Jardim B; Kollmann TR; Lacerda MVG; Lee KJ; Legge D; Lucas M; Lynn DJ; McDonald E; Manning L; Munns CF; Perrett KP; Prat Aymerich C; Richmond P; Shann F; Sudbury E; Villanueva P; Wood NJ; Lieschke K; Subbarao K; Davidson A; Curtis N; Abreu C; Addlem L; Agius S; Barbosa AAR; Alamrousi A; da Silva dos Santos AA; Al-Hindawi Y; Da Silveira SA; da Cruz LA; Anderson J; Anthony C; de Almeida dos Reis Pereira AAS; de las Revillas Almajano FA; Arnold A; Arrowsmith B; Azzopardi K; Marti CB; Bahaduri T; Barney S; Barrera L; Barriocanal A; Barros D; Bartlett A; Muranaka LBS; Baulman T; Bealing M; Beardsley J; Gutierrez ABM; Bell J; Bennett-Wood V; Bergant N; Barbosa FB; Bijllaardt W; Bimboese P; de Andrade CB; Blauwendraat K; Boersma W; Garcia PB; Bonnici R; Boon A; Bourke A; Bowes K; Brasil L; Brophy C; Buchanan S; Bucholc J; Burns A; Burrell E; Bustos N; Byrne B; Byrne A; Calbo E; Montes JC; Camesella B; Campbell J; Cangas A; Carlin J; Roque MC; Diogo RCP; Carvalho E; Casas I; Castro E; Castro R; Catterick H, 2021, 'BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2021-052101

Migliori GB; Marx FM; Ambrosino N; Zampogna E; Schaaf HS; van der Zalm MM; Allwood B; Byrne AL; Mortimer K; Wallis RS; Fox GJ; Leung CC; Chakaya JM; Seaworth B; Rachow A; Marais BJ; Furin J; Akkerman OW; Al Yaquobi F; Amaral AFS; Borisov S; Caminero JA; Carvalho ACC; Chesov D; Codecasa LR; Teixeira RC; Dalcolmo MP; Datta S; Dinh-Xuan AT; Duarte R; Evans CA; García-García JM; Günther G; Hoddinott G; Huddart S; Ivanova O; Laniado-Laborín R; Manga S; Manika K; Mariandyshev A; Mello FCQ; Mpagama SG; Muñoz-Torrico M; Nahid P; Ong CWM; Palmero DJ; Piubello A; Pontali E; Silva DR; Singla R; Spanevello A; Tiberi S; Udwadia ZF; Vitacca M; Centis R; D'Ambrosio L; Sotgiu G; Lange C; Visca D, 2021, 'Clinical standards for the assessment, management and rehabilitation of post-TB lung disease', International Journal of Tuberculosis and Lung Disease, 25, pp. 797 - 813, http://dx.doi.org/10.5588/ijtld.21.0425

Darley DR; Dore GJ; Byrne AL; Plit ML; Brew BJ; Kelleher A; Matthews GV, 2021, 'Limited recovery from post-acute sequelae of sars-cov-2 at 8 months in a prospective cohort', Erj Open Research, 7, http://dx.doi.org/10.1183/23120541.00384-2021

Allwood BW; Byrne A; Meghji J; Rachow A; Van Der Zalm MM; Schoch OD, 2021, 'Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge', Respiration, 100, pp. 751 - 763, http://dx.doi.org/10.1159/000512531

Joseph Y; Yao Z; Dua A; Severe P; Collins SE; Bang H; Antoine Jean-Juste M; Ocheretina O; Apollon A; McNairy ML; Dupnik K; Cremieux E; Byrne A; Pape JW; Koenig SP, 2021, 'Long-term mortality after tuberculosis treatment among persons living with HIV in Haiti', Journal of the International AIDS Society, 24, http://dx.doi.org/10.1002/jia2.25721

Alffenaar JW; Märtson AG; Heysell SK; Cho JG; Patanwala A; Burch G; Kim HY; Sturkenboom MGG; Byrne A; Marriott D; Sandaradura I; Tiberi S; Sintchencko V; Srivastava S; Peloquin CA, 2021, 'Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections', Clinical Pharmacokinetics, 60, pp. 711 - 725, http://dx.doi.org/10.1007/s40262-021-01000-6

Darley D; Matthews G; Dore G; Wilhelm K; Plit M; Stone E; Byrne A; Tonga K; Andresen D; Kelleher A; Cysique L; Cunningham P; Brew B, 2021, 'Persistent symptoms up to four months after community and hospital- managed SARS- CoV- 2 infection', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50963

Di Michiel J; Gawthorne J; Shivam A; Maruno K; Cohn S; Lemon C; Liu Z; Byrne A, 2021, 'Lung health in the solomon islands: A mixed methods study', International Journal of Copd, 16, pp. 3093 - 3103, http://dx.doi.org/10.2147/COPD.S331734

Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G, 2020, 'Burden of non-communicable diseases from infectious causes in 2017: a modelling study', Lancet Global Health, 8, pp. e1489 - e1498, http://dx.doi.org/10.1016/S2214-109X(20)30358-2

Allwood BW; Van Der Zalm MM; Amaral AFS; Byrne A; Datta S; Egere U; Evans CA; Evans D; Gray DM; Hoddinott G; Ivanova O; Jones R; Makanda G; Marx FM; Meghji J; Mpagama S; Pasipanodya JG; Rachow A; Schoeman I; Shaw J; Stek C; Van Kampen S; Von Delft D; Walker NF; Wallis RS; Mortimer K, 2020, 'Post-tuberculosis lung health: Perspectives from the First International Symposium', International Journal of Tuberculosis and Lung Disease, 24, pp. 820 - 828, http://dx.doi.org/10.5588/ijtld.20.0067

Robertson DJ; Sanders JG; Towler A; Kramer RSS; Spowage J; Byrne A; Burton AM; Jenkins R, 2020, 'Hyper-realistic Face Masks in a Live Passport-Checking Task', Perception, 49, pp. 298 - 309, http://dx.doi.org/10.1177/0301006620904614

Yeong C; Byrne AL; Cho JG; Sintchenko V; Crighton T; Marais BJ, 2020, 'Use of GeneXpert MTB/RIF on a single pooled sputum specimen to exclude pulmonary tuberculosis among hospital inpatients placed in respiratory isolation', International Journal of Infectious Diseases, 92, pp. 175 - 180, http://dx.doi.org/10.1016/j.ijid.2019.12.024

Byrne AL; Bennett MH; Chatterji R; Symons R; Thomas PS, 2020, 'Arterial and venous blood gases in exacerbations of chronic obstructive pulmonary disease', Internal Medicine Journal, 50, pp. 133 - 134, http://dx.doi.org/10.1111/imj.14692

Byrne AL; Marais BJ; Mitnick CD; Garden FL; Lecca L; Contreras C; Yauri Y; Garcia F; Marks GB, 2019, 'Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru', BMC Pulmonary Medicine, 19, pp. 40, http://dx.doi.org/10.1186/s12890-019-0804-z

Byrne AL; Fox GJ; Marais BJ, 2018, 'Better than a pound of cure: Preventing the development of multidrug-resistant tuberculosis', Future Microbiology, 13, pp. 577 - 588, http://dx.doi.org/10.2217/fmb-2017-0236

Byrne AL; Marais BJ; Mitnick CD; Garden FL; Lecca L; Contreras C; Yauri Y; Garcia F; Marks GB, 2018, 'Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru', International Journal of Tuberculosis and Lung Disease, 22, pp. 86 - 92, http://dx.doi.org/10.5588/ijtld.17.0381

Hovey EJ; Field KM; Rosenthal MA; Barnes EH; Cher L; Nowak AK; Wheeler H; Sawkins K; Livingstone A; Phal P; Goh C; Simes J; Hayden A; Barnes E; Espinoza D; Brown C; Winter D; Tomes B; Pike R; Garrett L; Kilsby H; Freilich R; Arzhintar I; Dowling A; Ranieri N; Jennens R; Osmond F; Patterson KW; Phay A; Byrne A; Begbie S; Williams P; Kirby-Lewis S; Abell F; Plowman L; Flynn J; Inglis P; Ives A; Lobb S; Lwin Z; Woodward N; Crosbie G; Singhal N; Smith S; Whelan M, 2017, 'Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: An exploratory randomized phase II trial', Neuro Oncology Practice, 4, pp. 171 - 181, http://dx.doi.org/10.1093/nop/npw025

Byrne AL; Marais BJ; Mitnick CD; Garden FL; Lecca L; Contreras C; Yauri Y; Garcia F; Marks GB, 2017, 'Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis', Erj Open Research, 3, pp. 00026 - 02017, http://dx.doi.org/10.1183/23120541.00026-2017

Ho J; Byrne AL; Linh NN; Jaramillo E; Fox GJ, 2017, 'Decentralized care for multidrug-resistant tuberculosis: A systematic review and meta-analysis', Bulletin of the World Health Organization, 95, pp. 584 - 593, http://dx.doi.org/10.2471/BLT.17.193375

Hayman YA; Sadofsky LR; Williamson JD; Hart SP; Morice AH, 2017, 'The effects of exogenous lipid on THP-1 cells: an in vitro model of airway aspiration?', ERJ Open Res, 3, http://dx.doi.org/10.1183/23120541.00026-2016

Field KM; Simes J; Nowak AK; Cher L; Wheeler H; Hovey EJ; Brown CSB; Barnes EH; Sawkins K; Livingstone A; Freilich R; Phal PM; Fitt G; Rosenthal MA; Arzhintar I; Garrett L; Byrne A; Dowling A; Ranieri N; Jennens R; Osmond F; Patterson WK; Phay A; Abell F; Plowman L; Flynn J; Hovey E; Kilsby H; Kirby-Lewis S; Singhal N; Smith S; Whelan M; Inglis P; Ives A; Lobb S; Begbie S; Williams P; Lwin Z; Woodward N; Crosbie G; Harrup R; Pyszkowski L; Gauden S; Neville A, 2015, 'Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma', Neuro Oncology, 17, pp. 1504 - 1513, http://dx.doi.org/10.1093/neuonc/nov104

Byrne AL; Marais BJ; Mitnick CD; Lecca L; Marks GB, 2015, 'Risk factors for and origins of COPD', Lancet, 385, pp. 1723 - 1724, http://dx.doi.org/10.1016/S0140-6736(15)60884-4

Byrne AL; Marais BJ; Mitnick CD; Lecca L; Marks GB, 2015, 'Tuberculosis and chronic respiratory disease: A systematic review', International Journal of Infectious Diseases, 32, pp. 138 - 146, http://dx.doi.org/10.1016/j.ijid.2014.12.016

Byrne AL; Bennett M; Chatterji R; Symons R; Pace NL; Thomas PS, 2014, 'Peripheral venous and arterial blood gas analysis in adults: Are they comparable? A systematic review and meta-analysis', Respirology, 19, pp. 168 - 175, http://dx.doi.org/10.1111/resp.12225

Byrne A; Bennett M; Chatterji R; Symons R; Pace N; Thomas P, 2014, 'Reply', Respirology, 19, pp. 769 - 770, http://dx.doi.org/10.1111/resp.12300

Byrne A; Bennett M; Chatterji R; Symons R; Pace N; Thomas P, 2014, 'Comparison of peripheral venous and arterial blood gas analyses Reply', RESPIROLOGY, 19, pp. 769 - 770, http://dx.doi.org/10.1111/resp.12300

Back to profile page